Author: Alberto Castro Molina MD

Obicetrapib Demonstrates Promising Lipid-Lowering Efficacy and Safety in Heterozygous Familial Hypercholesterolemia: BROOKLYN
AHA 2024, News

Obicetrapib Demonstrates Promising Lipid-Lowering Efficacy and Safety in Heterozygous Familial Hypercholesterolemia: BROOKLYN

Key Points: BROOKLYN was a phase III trial that assessed the safety and effectiveness of obicetrapib as an adjunct to maximally tolerated lipid-modifying therapies,... Read more.
SWEDEGRAFT Trial: No Advantage of No-Touch vs Conventional Vein Harvesting in Coronary Artery Bypass Surgery
ESC 2024, News

SWEDEGRAFT Trial: No Advantage of No-Touch vs Conventional Vein Harvesting in Coronary Artery Bypass Surgery

Key Points: The SWEDEGRAFT study is a prospective, binational multicenter, open-label, registry-based trial in patients undergoing first isolated non-emergent coronary... Read more.
AHA 2023, News

Recaticimab Effective as Add-On Therapy in Non-Familial Hypercholesterolaemia and Mixed Hyperlipidemia: REMAIN-2 Trial 

Key Points Recaticimab effectiveness demonstrated dosage-dependent response indicating versatility in treatment options. Sustained reduction in LDL-C levels throughout... Read more.